Option chain shows key data for MORPHOSYS AG ORD by MorphoSys AG's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for MORPHOSYS AG ORD by MorphoSys AG.

MORPHOSYS AG ORD by MorphoSys AG (OTC:MPSYF) Stock, Option Chain

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Intraday Update

Markets

Movers

Trading Ideas

AAVVF

ACAD

ACLLF

AFGC

ALAC

ALIAF

AMCI

APLT

ASRAF

AUPH

AWON

BRBR

CDAY

CDLX

CGOOF

CMRE

CMTL

CYSM

DCPH

DRETF

DXCM

Eaton Vance Tax-Advantaged Global Dividend

FLXN

FSUGY

FTAI

GBNXF

GEF-B

GLPG

GMICF

HEBT

ICTSF

IMPUY

INCY

INSG

INVU

ITOCY

KNTNF

LGRDY

LYTS

MAIFF

MAKOF

MITSY

MONRY

Morgan Stanley Capital Protected Notes for S&P 500 Index

MPSYF

Nfj Dividend Interest & Premium Strategy Fund

NMGNF

NSVGF

NTIOF

OGFGY

ORKLY

OYST

PFBC

PMNXF

PNFP

POWL

POYYF

PTCT

PWCDF

PWOD

RESI

RTMVY

SAFE

SAVA

SBGSY

SCFLF

SEAC

SGRY

SNEJF

SPWH

SRCL

THOR

TMOL

TTDKY

Stocks That Hit 52-Week Highs On Thursday

ABMBF

AGYS

AJRD

AKRO

AMRK

ANIK

APPN

ARCE

ATEC

ATLC

AURI

AVDR

AVLR

AZPN

BLDR

BMCH

CABGY

CABJF

CAFI

CAHPF

CASY

CECO

CEVA

CHPGF

CIBEY

CLSI

CNMD

CNNE

CSGS

CWST

CYRX

CYTK

DCGD

ECNCF

EIFZF

EMLAF

EMRAF

ENPH

ESLT

EVRG

FBPRM

FIVN

FTDR

GGDVY

GLDLF

GROW

HEI-A

HPGLY

HUBS

IBIDF

INXN

IOTS

IPHI

IRET

ITRI

JRVR

JUBPF

LZAGY

MELI

Stocks That Set New 52-Week Highs Thursday

MORPHOSYS AG ORD by MorphoSys AG

MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript

These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)

MorphoSys: Hold Rating Until The Novartis Deal Closes

Incyte: The Worst Has Been Avoided

ABBV

ADAP

APLM

APLMW

ASPHF

AUTL

BEIGF

BGNE

BMYMP

CRTHF

DAWN

DMPWW

DSKYF

DSNKY

GILD

GLAXF

IOVA

JBPHF

KTRA

MDNAF

NVCR

NVSEF

RCUS

REGN

RHHBF

RHHBY

RHHVF

SMMT

SNDX

SNYNF

SPHRF

SPHRY

SRRK

TKPHF

Biotech

Events

Press Releases

MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Earnings

Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Legal

Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders

Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting

Comments

MORPHOSYS AG ORD by MorphoSys AG

MORPHOSYS AG ORD by MorphoSys AG (MPSYF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga